The appropriate management for male partners of couples with
recurrent pregnancy loss (RPL) or recurrent implantation failure during in
vitro fertilization (IVF) remains unclear. In particular, men with normal
semen parameters are often ignored because the “bulk semen parameters”
appear normal. Despite normal semen parameters, male partners in couples with
RPL or recurrent implantation failure could have underlying genetic
abnormalities in sperm DNA that can be identified. There are a couple of
diagnostic tests that we recommend in the evaluation of these men, the first being
DNA Fragmentation Index (DFI) and the second, fluorescence in situ
hybridization (FISH) for evaluating sperm aneuploidy.
In particular, there are no repair mechanisms that
occur once sperm are transported to the epididymis or post ejaculation High DNA damage as demonstrated by increased DFI is associated with recurrent
pregnancy loss, recurrent IVF failure, and increased
congenital abnormalities. Therefore, men with abnormally elevated DFI can
undergo testicular biopsy for sperm retrieval and use with intracytoplasmic
sperm injection (ICSI) because DFI in testicular sperm is significantly lower
compared to DFI in ejaculated sperm.
There are several DFI assays
available, and each has its own set of advantages and disadvantages. The sperm
chromatin structure assay (SCSA) is commercially available, but the Terminal
deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling (TUNEL) assay, Halo
test, and Comet assay are other options.

No comments:
Post a Comment